Used in research settings as a selective inhibitor of fatty acid amide hydrolase (FAAH), enhancing endocannabinoid signaling. Shows potential in studying pain modulation, inflammation, and anxiety-related pathways. Investigated for its role in preclinical models to understand neurological and immune responses without directly activating cannabinoid receptors. Not approved for clinical use; strictly for laboratory research.